E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/8/2006 in the Prospect News Biotech Daily.

Minrad greenshoe exercised, raising stock issue to $37.375 million

By Lisa Kerner

Charlotte, N.C., June 8 - Minrad International, Inc. said the underwriters of its recent public offering of 10 million shares have exercised their over-allotment option to purchase an additional 1.5 million shares at $3.25 per share, or $4.875 million, raising the deal to $37.375 million.

Proceeds from the sale of these additional shares will be used for general corporate purposes.

Oppenheimer & Co. acted as lead managing underwriter of the offering. KeyBanc Capital Markets and Maxim Group LLC acted as co-managing underwriters.

Minrad priced the original 10 million shares at $3.25 after the close on May 23.

Located in Buffalo, N.Y., Minrad is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.